nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0771	0.139	CbGbCtD
Lercanidipine—CYP3A7—Estradiol—osteoporosis	0.0771	0.139	CbGbCtD
Lercanidipine—CYP3A5—Estradiol—osteoporosis	0.0579	0.104	CbGbCtD
Lercanidipine—CYP3A4—Estropipate—osteoporosis	0.0543	0.0978	CbGbCtD
Lercanidipine—CYP3A4—Calcitriol—osteoporosis	0.0543	0.0978	CbGbCtD
Lercanidipine—CYP2D6—Cholecalciferol—osteoporosis	0.044	0.0792	CbGbCtD
Lercanidipine—CYP3A4—Ergocalciferol—osteoporosis	0.0434	0.0782	CbGbCtD
Lercanidipine—CYP3A4—Raloxifene—osteoporosis	0.0363	0.0652	CbGbCtD
Lercanidipine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.035	0.063	CbGbCtD
Lercanidipine—CYP3A4—Cholecalciferol—osteoporosis	0.028	0.0504	CbGbCtD
Lercanidipine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0257	0.0462	CbGbCtD
Lercanidipine—CYP3A4—Estradiol—osteoporosis	0.0226	0.0406	CbGbCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—osteoporosis	0.000598	0.0219	CbGpPWpGaD
Lercanidipine—CACNA1C—Adrenaline,noradrenaline inhibits insulin secretion—ADCY5—osteoporosis	0.000574	0.0211	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—GAPDH—osteoporosis	0.000554	0.0203	CbGpPWpGaD
Lercanidipine—CACNA1D—Regulation of insulin secretion—RAP1A—osteoporosis	0.000551	0.0202	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—GAPDH—osteoporosis	0.000487	0.0179	CbGpPWpGaD
Lercanidipine—CACNA1C—Regulation of insulin secretion—RAP1A—osteoporosis	0.000484	0.0178	CbGpPWpGaD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000445	0.0163	CbGpPWpGaD
Lercanidipine—CYP3A7—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000439	0.0161	CbGpPWpGaD
Lercanidipine—CACNA1D—Integration of energy metabolism—RAP1A—osteoporosis	0.000433	0.0159	CbGpPWpGaD
Lercanidipine—CACNA1C—Integration of energy metabolism—RAP1A—osteoporosis	0.000381	0.014	CbGpPWpGaD
Lercanidipine—Arthralgia—Zoledronate—osteoporosis	0.000368	0.000883	CcSEcCtD
Lercanidipine—Chest pain—Zoledronate—osteoporosis	0.000368	0.000883	CcSEcCtD
Lercanidipine—Myalgia—Zoledronate—osteoporosis	0.000368	0.000883	CcSEcCtD
Lercanidipine—Palpitations—Conjugated Estrogens—osteoporosis	0.000368	0.000883	CcSEcCtD
Lercanidipine—Insomnia—Risedronate—osteoporosis	0.000368	0.000882	CcSEcCtD
Lercanidipine—Anxiety—Zoledronate—osteoporosis	0.000367	0.00088	CcSEcCtD
Lercanidipine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000366	0.000878	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000366	0.000877	CcSEcCtD
Lercanidipine—Paraesthesia—Risedronate—osteoporosis	0.000365	0.000875	CcSEcCtD
Lercanidipine—Pruritus—Estropipate—osteoporosis	0.000364	0.000873	CcSEcCtD
Lercanidipine—Discomfort—Zoledronate—osteoporosis	0.000364	0.000872	CcSEcCtD
Lercanidipine—Asthenia—Alendronate—osteoporosis	0.000363	0.000872	CcSEcCtD
Lercanidipine—Hypersensitivity—Ibandronate—osteoporosis	0.000363	0.000871	CcSEcCtD
Lercanidipine—Cough—Conjugated Estrogens—osteoporosis	0.000363	0.000871	CcSEcCtD
Lercanidipine—Dyspnoea—Risedronate—osteoporosis	0.000362	0.000869	CcSEcCtD
Lercanidipine—Erythema multiforme—Estradiol—osteoporosis	0.000362	0.000868	CcSEcCtD
Lercanidipine—Hypotension—Pamidronate—osteoporosis	0.000361	0.000866	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000361	0.0132	CbGpPWpGaD
Lercanidipine—Dry mouth—Zoledronate—osteoporosis	0.00036	0.000864	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00036	0.000863	CcSEcCtD
Lercanidipine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000359	0.000862	CcSEcCtD
Lercanidipine—Pruritus—Alendronate—osteoporosis	0.000358	0.00086	CcSEcCtD
Lercanidipine—Dyspepsia—Risedronate—osteoporosis	0.000358	0.000858	CcSEcCtD
Lercanidipine—Eye disorder—Estradiol—osteoporosis	0.000358	0.000858	CcSEcCtD
Lercanidipine—Tinnitus—Estradiol—osteoporosis	0.000357	0.000856	CcSEcCtD
Lercanidipine—Constipation—Ethinyl Estradiol—osteoporosis	0.000357	0.000855	CcSEcCtD
Lercanidipine—Confusional state—Zoledronate—osteoporosis	0.000356	0.000853	CcSEcCtD
Lercanidipine—Hypersensitivity—Calcitriol—osteoporosis	0.000356	0.000853	CcSEcCtD
Lercanidipine—Flushing—Estradiol—osteoporosis	0.000355	0.000852	CcSEcCtD
Lercanidipine—Cardiac disorder—Estradiol—osteoporosis	0.000355	0.000852	CcSEcCtD
Lercanidipine—Myalgia—Conjugated Estrogens—osteoporosis	0.000355	0.00085	CcSEcCtD
Lercanidipine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000355	0.00085	CcSEcCtD
Lercanidipine—Chest pain—Conjugated Estrogens—osteoporosis	0.000355	0.00085	CcSEcCtD
Lercanidipine—Asthenia—Ibandronate—osteoporosis	0.000354	0.000849	CcSEcCtD
Lercanidipine—Anxiety—Conjugated Estrogens—osteoporosis	0.000353	0.000847	CcSEcCtD
Lercanidipine—Nausea—Etidronic acid—osteoporosis	0.000353	0.000847	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000352	0.000844	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000352	0.000844	CcSEcCtD
Lercanidipine—Diarrhoea—Estropipate—osteoporosis	0.000352	0.000844	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000351	0.000842	CcSEcCtD
Lercanidipine—Fatigue—Risedronate—osteoporosis	0.00035	0.00084	CcSEcCtD
Lercanidipine—Insomnia—Pamidronate—osteoporosis	0.000349	0.000838	CcSEcCtD
Lercanidipine—Pruritus—Ibandronate—osteoporosis	0.000349	0.000837	CcSEcCtD
Lercanidipine—Constipation—Risedronate—osteoporosis	0.000348	0.000834	CcSEcCtD
Lercanidipine—Angiopathy—Estradiol—osteoporosis	0.000347	0.000833	CcSEcCtD
Lercanidipine—Shock—Zoledronate—osteoporosis	0.000347	0.000833	CcSEcCtD
Lercanidipine—Paraesthesia—Pamidronate—osteoporosis	0.000347	0.000832	CcSEcCtD
Lercanidipine—Diarrhoea—Alendronate—osteoporosis	0.000347	0.000831	CcSEcCtD
Lercanidipine—Asthenia—Calcitriol—osteoporosis	0.000346	0.000831	CcSEcCtD
Lercanidipine—Nervous system disorder—Zoledronate—osteoporosis	0.000346	0.00083	CcSEcCtD
Lercanidipine—Immune system disorder—Estradiol—osteoporosis	0.000346	0.000829	CcSEcCtD
Lercanidipine—Thrombocytopenia—Zoledronate—osteoporosis	0.000346	0.000829	CcSEcCtD
Lercanidipine—Mediastinal disorder—Estradiol—osteoporosis	0.000345	0.000827	CcSEcCtD
Lercanidipine—Dyspnoea—Pamidronate—osteoporosis	0.000344	0.000826	CcSEcCtD
Lercanidipine—Tachycardia—Zoledronate—osteoporosis	0.000344	0.000826	CcSEcCtD
Lercanidipine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000344	0.000824	CcSEcCtD
Lercanidipine—Somnolence—Pamidronate—osteoporosis	0.000344	0.000824	CcSEcCtD
Lercanidipine—Skin disorder—Zoledronate—osteoporosis	0.000343	0.000822	CcSEcCtD
Lercanidipine—Pruritus—Calcitriol—osteoporosis	0.000342	0.000819	CcSEcCtD
Lercanidipine—Hyperhidrosis—Zoledronate—osteoporosis	0.000341	0.000818	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000341	0.000818	CcSEcCtD
Lercanidipine—Diarrhoea—Raloxifene—osteoporosis	0.000341	0.000817	CcSEcCtD
Lercanidipine—Dyspepsia—Pamidronate—osteoporosis	0.00034	0.000816	CcSEcCtD
Lercanidipine—Dizziness—Estropipate—osteoporosis	0.00034	0.000816	CcSEcCtD
Lercanidipine—Alopecia—Estradiol—osteoporosis	0.000338	0.000811	CcSEcCtD
Lercanidipine—CACNA1D—Axon guidance—CAP1—osteoporosis	0.000338	0.0124	CbGpPWpGaD
Lercanidipine—Diarrhoea—Ibandronate—osteoporosis	0.000337	0.000809	CcSEcCtD
Lercanidipine—Anorexia—Zoledronate—osteoporosis	0.000336	0.000807	CcSEcCtD
Lercanidipine—Decreased appetite—Pamidronate—osteoporosis	0.000336	0.000806	CcSEcCtD
Lercanidipine—Mental disorder—Estradiol—osteoporosis	0.000335	0.000804	CcSEcCtD
Lercanidipine—Dizziness—Alendronate—osteoporosis	0.000335	0.000803	CcSEcCtD
Lercanidipine—Shock—Conjugated Estrogens—osteoporosis	0.000334	0.000802	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000334	0.0008	CcSEcCtD
Lercanidipine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000333	0.000799	CcSEcCtD
Lercanidipine—Malnutrition—Estradiol—osteoporosis	0.000333	0.000799	CcSEcCtD
Lercanidipine—Erythema—Estradiol—osteoporosis	0.000333	0.000799	CcSEcCtD
Lercanidipine—Fatigue—Pamidronate—osteoporosis	0.000333	0.000799	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Risedronate—osteoporosis	0.000332	0.000797	CcSEcCtD
Lercanidipine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000332	0.000795	CcSEcCtD
Lercanidipine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000331	0.000794	CcSEcCtD
Lercanidipine—Constipation—Pamidronate—osteoporosis	0.00033	0.000792	CcSEcCtD
Lercanidipine—Diarrhoea—Calcitriol—osteoporosis	0.00033	0.000792	CcSEcCtD
Lercanidipine—Skin disorder—Conjugated Estrogens—osteoporosis	0.00033	0.000792	CcSEcCtD
Lercanidipine—Hypotension—Zoledronate—osteoporosis	0.00033	0.000791	CcSEcCtD
Lercanidipine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00033	0.00079	CcSEcCtD
Lercanidipine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00033	0.00079	CcSEcCtD
Lercanidipine—Dizziness—Raloxifene—osteoporosis	0.000329	0.00079	CcSEcCtD
Lercanidipine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000329	0.000788	CcSEcCtD
Lercanidipine—Tension—Estradiol—osteoporosis	0.000327	0.000784	CcSEcCtD
Lercanidipine—Vomiting—Estropipate—osteoporosis	0.000327	0.000784	CcSEcCtD
Lercanidipine—Dysgeusia—Estradiol—osteoporosis	0.000326	0.000783	CcSEcCtD
Lercanidipine—Dizziness—Ibandronate—osteoporosis	0.000326	0.000782	CcSEcCtD
Lercanidipine—Rash—Estropipate—osteoporosis	0.000324	0.000778	CcSEcCtD
Lercanidipine—Dermatitis—Estropipate—osteoporosis	0.000324	0.000777	CcSEcCtD
Lercanidipine—Anorexia—Conjugated Estrogens—osteoporosis	0.000324	0.000777	CcSEcCtD
Lercanidipine—Nervousness—Estradiol—osteoporosis	0.000324	0.000776	CcSEcCtD
Lercanidipine—Urticaria—Risedronate—osteoporosis	0.000323	0.000774	CcSEcCtD
Lercanidipine—Headache—Estropipate—osteoporosis	0.000322	0.000773	CcSEcCtD
Lercanidipine—Vomiting—Alendronate—osteoporosis	0.000322	0.000772	CcSEcCtD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000322	0.0118	CbGpPWpGaD
Lercanidipine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000322	0.000771	CcSEcCtD
Lercanidipine—Abdominal pain—Risedronate—osteoporosis	0.000321	0.000771	CcSEcCtD
Lercanidipine—Body temperature increased—Risedronate—osteoporosis	0.000321	0.000771	CcSEcCtD
Lercanidipine—Muscle spasms—Estradiol—osteoporosis	0.00032	0.000768	CcSEcCtD
Lercanidipine—Rash—Alendronate—osteoporosis	0.000319	0.000766	CcSEcCtD
Lercanidipine—Insomnia—Zoledronate—osteoporosis	0.000319	0.000766	CcSEcCtD
Lercanidipine—Dermatitis—Alendronate—osteoporosis	0.000319	0.000765	CcSEcCtD
Lercanidipine—Feeling abnormal—Pamidronate—osteoporosis	0.000318	0.000764	CcSEcCtD
Lercanidipine—CYP3A5—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000318	0.0116	CbGpPWpGaD
Lercanidipine—Hypotension—Conjugated Estrogens—osteoporosis	0.000318	0.000762	CcSEcCtD
Lercanidipine—Headache—Alendronate—osteoporosis	0.000317	0.000761	CcSEcCtD
Lercanidipine—Paraesthesia—Zoledronate—osteoporosis	0.000317	0.00076	CcSEcCtD
Lercanidipine—Vomiting—Raloxifene—osteoporosis	0.000317	0.00076	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000316	0.000758	CcSEcCtD
Lercanidipine—Dyspnoea—Zoledronate—osteoporosis	0.000315	0.000755	CcSEcCtD
Lercanidipine—Rash—Raloxifene—osteoporosis	0.000314	0.000753	CcSEcCtD
Lercanidipine—Dermatitis—Raloxifene—osteoporosis	0.000314	0.000753	CcSEcCtD
Lercanidipine—Somnolence—Zoledronate—osteoporosis	0.000314	0.000752	CcSEcCtD
Lercanidipine—Vomiting—Ibandronate—osteoporosis	0.000314	0.000752	CcSEcCtD
Lercanidipine—Headache—Raloxifene—osteoporosis	0.000312	0.000749	CcSEcCtD
Lercanidipine—Rash—Ibandronate—osteoporosis	0.000311	0.000746	CcSEcCtD
Lercanidipine—Dermatitis—Ibandronate—osteoporosis	0.000311	0.000745	CcSEcCtD
Lercanidipine—Dyspepsia—Zoledronate—osteoporosis	0.000311	0.000745	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00031	0.000743	CcSEcCtD
Lercanidipine—Ill-defined disorder—Estradiol—osteoporosis	0.000309	0.000742	CcSEcCtD
Lercanidipine—Headache—Ibandronate—osteoporosis	0.000309	0.000741	CcSEcCtD
Lercanidipine—Insomnia—Conjugated Estrogens—osteoporosis	0.000307	0.000737	CcSEcCtD
Lercanidipine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000307	0.000737	CcSEcCtD
Lercanidipine—Vomiting—Calcitriol—osteoporosis	0.000307	0.000736	CcSEcCtD
Lercanidipine—Decreased appetite—Zoledronate—osteoporosis	0.000307	0.000736	CcSEcCtD
Lercanidipine—Nausea—Estropipate—osteoporosis	0.000306	0.000733	CcSEcCtD
Lercanidipine—Body temperature increased—Pamidronate—osteoporosis	0.000305	0.000733	CcSEcCtD
Lercanidipine—Abdominal pain—Pamidronate—osteoporosis	0.000305	0.000733	CcSEcCtD
Lercanidipine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000305	0.000732	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000305	0.000731	CcSEcCtD
Lercanidipine—Angioedema—Estradiol—osteoporosis	0.000305	0.00073	CcSEcCtD
Lercanidipine—Rash—Calcitriol—osteoporosis	0.000304	0.00073	CcSEcCtD
Lercanidipine—Fatigue—Zoledronate—osteoporosis	0.000304	0.00073	CcSEcCtD
Lercanidipine—Dermatitis—Calcitriol—osteoporosis	0.000304	0.000729	CcSEcCtD
Lercanidipine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000303	0.000727	CcSEcCtD
Lercanidipine—Headache—Calcitriol—osteoporosis	0.000302	0.000725	CcSEcCtD
Lercanidipine—Somnolence—Conjugated Estrogens—osteoporosis	0.000302	0.000725	CcSEcCtD
Lercanidipine—Constipation—Zoledronate—osteoporosis	0.000302	0.000724	CcSEcCtD
Lercanidipine—Nausea—Alendronate—osteoporosis	0.000301	0.000722	CcSEcCtD
Lercanidipine—Malaise—Estradiol—osteoporosis	0.000301	0.000721	CcSEcCtD
Lercanidipine—Hypersensitivity—Risedronate—osteoporosis	0.000299	0.000718	CcSEcCtD
Lercanidipine—Vertigo—Estradiol—osteoporosis	0.000299	0.000718	CcSEcCtD
Lercanidipine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000299	0.000717	CcSEcCtD
Lercanidipine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000299	0.000717	CcSEcCtD
Lercanidipine—Syncope—Estradiol—osteoporosis	0.000299	0.000717	CcSEcCtD
Lercanidipine—CACNA1C—Axon guidance—CAP1—osteoporosis	0.000297	0.0109	CbGpPWpGaD
Lercanidipine—Nausea—Raloxifene—osteoporosis	0.000296	0.00071	CcSEcCtD
Lercanidipine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000295	0.000708	CcSEcCtD
Lercanidipine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000295	0.000707	CcSEcCtD
Lercanidipine—Palpitations—Estradiol—osteoporosis	0.000295	0.000706	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000293	0.000704	CcSEcCtD
Lercanidipine—Fatigue—Conjugated Estrogens—osteoporosis	0.000293	0.000703	CcSEcCtD
Lercanidipine—Nausea—Ibandronate—osteoporosis	0.000293	0.000703	CcSEcCtD
Lercanidipine—Loss of consciousness—Estradiol—osteoporosis	0.000293	0.000702	CcSEcCtD
Lercanidipine—Asthenia—Risedronate—osteoporosis	0.000292	0.000699	CcSEcCtD
Lercanidipine—CACNA1D—Regulation of insulin secretion—ADCY5—osteoporosis	0.000291	0.0107	CbGpPWpGaD
Lercanidipine—Feeling abnormal—Zoledronate—osteoporosis	0.000291	0.000698	CcSEcCtD
Lercanidipine—Cough—Estradiol—osteoporosis	0.000291	0.000697	CcSEcCtD
Lercanidipine—Constipation—Conjugated Estrogens—osteoporosis	0.000291	0.000697	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000289	0.000692	CcSEcCtD
Lercanidipine—Pruritus—Risedronate—osteoporosis	0.000288	0.00069	CcSEcCtD
Lercanidipine—Nausea—Calcitriol—osteoporosis	0.000287	0.000688	CcSEcCtD
Lercanidipine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000285	0.000684	CcSEcCtD
Lercanidipine—Hypersensitivity—Pamidronate—osteoporosis	0.000285	0.000683	CcSEcCtD
Lercanidipine—Arthralgia—Estradiol—osteoporosis	0.000284	0.00068	CcSEcCtD
Lercanidipine—Chest pain—Estradiol—osteoporosis	0.000284	0.00068	CcSEcCtD
Lercanidipine—Myalgia—Estradiol—osteoporosis	0.000284	0.00068	CcSEcCtD
Lercanidipine—Anxiety—Estradiol—osteoporosis	0.000283	0.000678	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000282	0.000676	CcSEcCtD
Lercanidipine—Urticaria—Zoledronate—osteoporosis	0.00028	0.000672	CcSEcCtD
Lercanidipine—Discomfort—Estradiol—osteoporosis	0.00028	0.000672	CcSEcCtD
Lercanidipine—Body temperature increased—Zoledronate—osteoporosis	0.000279	0.000669	CcSEcCtD
Lercanidipine—Abdominal pain—Zoledronate—osteoporosis	0.000279	0.000669	CcSEcCtD
Lercanidipine—Diarrhoea—Risedronate—osteoporosis	0.000278	0.000667	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000278	0.000666	CcSEcCtD
Lercanidipine—Dry mouth—Estradiol—osteoporosis	0.000277	0.000665	CcSEcCtD
Lercanidipine—Asthenia—Pamidronate—osteoporosis	0.000277	0.000665	CcSEcCtD
Lercanidipine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000276	0.000661	CcSEcCtD
Lercanidipine—Confusional state—Estradiol—osteoporosis	0.000274	0.000658	CcSEcCtD
Lercanidipine—Pruritus—Pamidronate—osteoporosis	0.000273	0.000656	CcSEcCtD
Lercanidipine—Urticaria—Conjugated Estrogens—osteoporosis	0.00027	0.000647	CcSEcCtD
Lercanidipine—Dizziness—Risedronate—osteoporosis	0.000269	0.000645	CcSEcCtD
Lercanidipine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000269	0.000644	CcSEcCtD
Lercanidipine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000269	0.000644	CcSEcCtD
Lercanidipine—Shock—Estradiol—osteoporosis	0.000268	0.000642	CcSEcCtD
Lercanidipine—Nervous system disorder—Estradiol—osteoporosis	0.000267	0.00064	CcSEcCtD
Lercanidipine—Tachycardia—Estradiol—osteoporosis	0.000265	0.000637	CcSEcCtD
Lercanidipine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000265	0.000636	CcSEcCtD
Lercanidipine—Diarrhoea—Pamidronate—osteoporosis	0.000264	0.000634	CcSEcCtD
Lercanidipine—Skin disorder—Estradiol—osteoporosis	0.000264	0.000634	CcSEcCtD
Lercanidipine—Hyperhidrosis—Estradiol—osteoporosis	0.000263	0.000631	CcSEcCtD
Lercanidipine—Rash—Ethinyl Estradiol—osteoporosis	0.000263	0.00063	CcSEcCtD
Lercanidipine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000263	0.00063	CcSEcCtD
Lercanidipine—Headache—Ethinyl Estradiol—osteoporosis	0.000261	0.000626	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000261	0.00957	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Zoledronate—osteoporosis	0.00026	0.000624	CcSEcCtD
Lercanidipine—Vomiting—Risedronate—osteoporosis	0.000258	0.00062	CcSEcCtD
Lercanidipine—Rash—Risedronate—osteoporosis	0.000256	0.000615	CcSEcCtD
Lercanidipine—Dermatitis—Risedronate—osteoporosis	0.000256	0.000614	CcSEcCtD
Lercanidipine—CACNA1C—Regulation of insulin secretion—ADCY5—osteoporosis	0.000256	0.00938	CbGpPWpGaD
Lercanidipine—Dizziness—Pamidronate—osteoporosis	0.000256	0.000613	CcSEcCtD
Lercanidipine—Headache—Risedronate—osteoporosis	0.000255	0.000611	CcSEcCtD
Lercanidipine—Asthenia—Zoledronate—osteoporosis	0.000253	0.000607	CcSEcCtD
Lercanidipine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00025	0.0006	CcSEcCtD
Lercanidipine—Pruritus—Zoledronate—osteoporosis	0.00025	0.000599	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000248	0.000594	CcSEcCtD
Lercanidipine—Nausea—Ethinyl Estradiol—osteoporosis	0.000248	0.000594	CcSEcCtD
Lercanidipine—Insomnia—Estradiol—osteoporosis	0.000246	0.00059	CcSEcCtD
Lercanidipine—Vomiting—Pamidronate—osteoporosis	0.000246	0.000589	CcSEcCtD
Lercanidipine—Paraesthesia—Estradiol—osteoporosis	0.000244	0.000586	CcSEcCtD
Lercanidipine—Asthenia—Conjugated Estrogens—osteoporosis	0.000244	0.000585	CcSEcCtD
Lercanidipine—Rash—Pamidronate—osteoporosis	0.000244	0.000584	CcSEcCtD
Lercanidipine—Dermatitis—Pamidronate—osteoporosis	0.000243	0.000584	CcSEcCtD
Lercanidipine—Dyspnoea—Estradiol—osteoporosis	0.000242	0.000582	CcSEcCtD
Lercanidipine—Headache—Pamidronate—osteoporosis	0.000242	0.000581	CcSEcCtD
Lercanidipine—Somnolence—Estradiol—osteoporosis	0.000242	0.00058	CcSEcCtD
Lercanidipine—Diarrhoea—Zoledronate—osteoporosis	0.000241	0.000579	CcSEcCtD
Lercanidipine—Nausea—Risedronate—osteoporosis	0.000241	0.000579	CcSEcCtD
Lercanidipine—CACNA1D—Developmental Biology—CAP1—osteoporosis	0.000241	0.00885	CbGpPWpGaD
Lercanidipine—Pruritus—Conjugated Estrogens—osteoporosis	0.00024	0.000577	CcSEcCtD
Lercanidipine—Dyspepsia—Estradiol—osteoporosis	0.000239	0.000574	CcSEcCtD
Lercanidipine—Decreased appetite—Estradiol—osteoporosis	0.000236	0.000567	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000235	0.000563	CcSEcCtD
Lercanidipine—Fatigue—Estradiol—osteoporosis	0.000235	0.000562	CcSEcCtD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000234	0.00858	CbGpPWpGaD
Lercanidipine—Dizziness—Zoledronate—osteoporosis	0.000233	0.00056	CcSEcCtD
Lercanidipine—Constipation—Estradiol—osteoporosis	0.000233	0.000558	CcSEcCtD
Lercanidipine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000233	0.000558	CcSEcCtD
Lercanidipine—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000231	0.00847	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—IL6R—osteoporosis	0.000231	0.00846	CbGpPWpGaD
Lercanidipine—Nausea—Pamidronate—osteoporosis	0.00023	0.00055	CcSEcCtD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000229	0.00839	CbGpPWpGaD
Lercanidipine—CACNA1D—Integration of energy metabolism—ADCY5—osteoporosis	0.000229	0.00839	CbGpPWpGaD
Lercanidipine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000226	0.00828	CbGpPWpGaD
Lercanidipine—Dizziness—Conjugated Estrogens—osteoporosis	0.000225	0.000539	CcSEcCtD
Lercanidipine—Vomiting—Zoledronate—osteoporosis	0.000224	0.000538	CcSEcCtD
Lercanidipine—Feeling abnormal—Estradiol—osteoporosis	0.000224	0.000538	CcSEcCtD
Lercanidipine—Rash—Zoledronate—osteoporosis	0.000223	0.000534	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Estradiol—osteoporosis	0.000222	0.000533	CcSEcCtD
Lercanidipine—Dermatitis—Zoledronate—osteoporosis	0.000222	0.000533	CcSEcCtD
Lercanidipine—Headache—Zoledronate—osteoporosis	0.000221	0.00053	CcSEcCtD
Lercanidipine—Vomiting—Conjugated Estrogens—osteoporosis	0.000216	0.000518	CcSEcCtD
Lercanidipine—Urticaria—Estradiol—osteoporosis	0.000216	0.000518	CcSEcCtD
Lercanidipine—Body temperature increased—Estradiol—osteoporosis	0.000215	0.000516	CcSEcCtD
Lercanidipine—Abdominal pain—Estradiol—osteoporosis	0.000215	0.000516	CcSEcCtD
Lercanidipine—Rash—Conjugated Estrogens—osteoporosis	0.000214	0.000514	CcSEcCtD
Lercanidipine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000214	0.000513	CcSEcCtD
Lercanidipine—Headache—Conjugated Estrogens—osteoporosis	0.000213	0.000511	CcSEcCtD
Lercanidipine—CACNA1C—Developmental Biology—CAP1—osteoporosis	0.000212	0.00777	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—TLN1—osteoporosis	0.000212	0.00777	CbGpPWpGaD
Lercanidipine—Nausea—Zoledronate—osteoporosis	0.00021	0.000503	CcSEcCtD
Lercanidipine—CACNA1D—Axon guidance—ACTG1—osteoporosis	0.000209	0.00766	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—IL6R—osteoporosis	0.000203	0.00743	CbGpPWpGaD
Lercanidipine—Nausea—Conjugated Estrogens—osteoporosis	0.000202	0.000484	CcSEcCtD
Lercanidipine—CACNA1C—Integration of energy metabolism—ADCY5—osteoporosis	0.000201	0.00737	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Estradiol—osteoporosis	0.0002	0.000481	CcSEcCtD
Lercanidipine—Asthenia—Estradiol—osteoporosis	0.000195	0.000468	CcSEcCtD
Lercanidipine—Pruritus—Estradiol—osteoporosis	0.000192	0.000461	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—CYP27A1—osteoporosis	0.000192	0.00703	CbGpPWpGaD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00019	0.00695	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—CYP27A1—osteoporosis	0.000189	0.00694	CbGpPWpGaD
Lercanidipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000188	0.00691	CbGpPWpGaD
Lercanidipine—Diarrhoea—Estradiol—osteoporosis	0.000186	0.000446	CcSEcCtD
Lercanidipine—CACNA1C—Axon guidance—TLN1—osteoporosis	0.000186	0.00682	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000186	0.0068	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—ACTG1—osteoporosis	0.000184	0.00673	CbGpPWpGaD
Lercanidipine—Dizziness—Estradiol—osteoporosis	0.00018	0.000431	CcSEcCtD
Lercanidipine—Vomiting—Estradiol—osteoporosis	0.000173	0.000415	CcSEcCtD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.000172	0.00629	CbGpPWpGaD
Lercanidipine—Rash—Estradiol—osteoporosis	0.000172	0.000411	CcSEcCtD
Lercanidipine—Dermatitis—Estradiol—osteoporosis	0.000171	0.000411	CcSEcCtD
Lercanidipine—Headache—Estradiol—osteoporosis	0.00017	0.000409	CcSEcCtD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000169	0.0062	CbGpPWpGaD
Lercanidipine—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000167	0.00612	CbGpPWpGaD
Lercanidipine—Nausea—Estradiol—osteoporosis	0.000162	0.000387	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—IL1B—osteoporosis	0.000156	0.00571	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TLN1—osteoporosis	0.000151	0.00554	CbGpPWpGaD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.000151	0.00553	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00015	0.00549	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—ACTG1—osteoporosis	0.000149	0.00547	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000148	0.00542	CbGpPWpGaD
Lercanidipine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000141	0.00517	CbGpPWpGaD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000141	0.00516	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	0.000139	0.00508	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000137	0.00503	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	0.000137	0.00501	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—IL1B—osteoporosis	0.000137	0.00501	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TLN1—osteoporosis	0.000133	0.00487	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—ACTG1—osteoporosis	0.000131	0.0048	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000121	0.00445	CbGpPWpGaD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00012	0.00441	CbGpPWpGaD
Lercanidipine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000119	0.00435	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—WNT1—osteoporosis	0.000116	0.00426	CbGpPWpGaD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000114	0.00418	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—TNF—osteoporosis	0.000113	0.00414	CbGpPWpGaD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000108	0.00397	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PKM—osteoporosis	0.000106	0.00389	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—FDPS—osteoporosis	0.000106	0.00389	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—osteoporosis	0.000103	0.00377	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—WNT1—osteoporosis	0.000102	0.00374	CbGpPWpGaD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000102	0.00373	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	0.000101	0.00369	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GPD2—osteoporosis	0.000101	0.00369	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PGLS—osteoporosis	0.000101	0.00369	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	9.93e-05	0.00364	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—TNF—osteoporosis	9.92e-05	0.00364	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	9.86e-05	0.00361	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.75e-05	0.00357	CbGpPWpGaD
Lercanidipine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	9.72e-05	0.00357	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	9.72e-05	0.00356	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PKM—osteoporosis	9.32e-05	0.00342	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—FDPS—osteoporosis	9.32e-05	0.00342	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ATIC—osteoporosis	9.2e-05	0.00337	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PNP—osteoporosis	9.2e-05	0.00337	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—osteoporosis	9.02e-05	0.00331	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PGLS—osteoporosis	8.84e-05	0.00324	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GPD2—osteoporosis	8.84e-05	0.00324	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.24e-05	0.00302	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PNP—osteoporosis	8.08e-05	0.00296	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ATIC—osteoporosis	8.08e-05	0.00296	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.86e-05	0.00288	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CA2—osteoporosis	7.82e-05	0.00287	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—OXCT1—osteoporosis	7.82e-05	0.00287	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.76e-05	0.00284	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—MGLL—osteoporosis	7.62e-05	0.0028	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	7.28e-05	0.00267	CbGpPWpGaD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.23e-05	0.00265	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	7.18e-05	0.00263	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—OXCT1—osteoporosis	6.87e-05	0.00252	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CA2—osteoporosis	6.87e-05	0.00252	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—MGLL—osteoporosis	6.7e-05	0.00246	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—IL6R—osteoporosis	6.61e-05	0.00243	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—IDH2—osteoporosis	6.48e-05	0.00238	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	6.44e-05	0.00236	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.37e-05	0.00234	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	6.36e-05	0.00233	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP27A1—osteoporosis	6.09e-05	0.00224	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—POMC—osteoporosis	6.05e-05	0.00222	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ACP5—osteoporosis	5.93e-05	0.00217	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.86e-05	0.00215	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—IL6R—osteoporosis	5.81e-05	0.00213	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PKM—osteoporosis	5.71e-05	0.00209	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—FDPS—osteoporosis	5.71e-05	0.00209	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—IDH2—osteoporosis	5.7e-05	0.00209	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—LEP—osteoporosis	5.63e-05	0.00207	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—TPI1—osteoporosis	5.51e-05	0.00202	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GPD2—osteoporosis	5.41e-05	0.00198	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PGLS—osteoporosis	5.41e-05	0.00198	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP27A1—osteoporosis	5.36e-05	0.00196	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ACP5—osteoporosis	5.21e-05	0.00191	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—P4HB—osteoporosis	5.18e-05	0.0019	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	5.18e-05	0.0019	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	5.11e-05	0.00187	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GAPDH—osteoporosis	5.09e-05	0.00187	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—RAP1A—osteoporosis	4.95e-05	0.00182	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PNP—osteoporosis	4.95e-05	0.00182	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ATIC—osteoporosis	4.95e-05	0.00182	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—LEP—osteoporosis	4.95e-05	0.00181	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—TPI1—osteoporosis	4.84e-05	0.00178	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.72e-05	0.00173	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—IL6R—osteoporosis	4.72e-05	0.00173	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—P4HB—osteoporosis	4.55e-05	0.00167	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GAPDH—osteoporosis	4.47e-05	0.00164	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—POMC—osteoporosis	4.38e-05	0.0016	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—RAP1A—osteoporosis	4.35e-05	0.0016	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CA2—osteoporosis	4.21e-05	0.00154	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—OXCT1—osteoporosis	4.21e-05	0.00154	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—IL6R—osteoporosis	4.15e-05	0.00152	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PKM—osteoporosis	4.13e-05	0.00151	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—FDPS—osteoporosis	4.13e-05	0.00151	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MGLL—osteoporosis	4.1e-05	0.0015	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ENO1—osteoporosis	4e-05	0.00147	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PSMA2—osteoporosis	3.95e-05	0.00145	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PSMA5—osteoporosis	3.95e-05	0.00145	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PGLS—osteoporosis	3.91e-05	0.00143	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GPD2—osteoporosis	3.91e-05	0.00143	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.83e-05	0.0014	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ATIC—osteoporosis	3.58e-05	0.00131	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PNP—osteoporosis	3.58e-05	0.00131	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ENO1—osteoporosis	3.52e-05	0.00129	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—IDH2—osteoporosis	3.49e-05	0.00128	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PSMA2—osteoporosis	3.47e-05	0.00127	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PSMA5—osteoporosis	3.47e-05	0.00127	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.39e-05	0.00124	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.34e-05	0.00122	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP27A1—osteoporosis	3.28e-05	0.0012	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP19A1—osteoporosis	3.2e-05	0.00117	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ACP5—osteoporosis	3.19e-05	0.00117	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—POMC—osteoporosis	3.11e-05	0.00114	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—OXCT1—osteoporosis	3.04e-05	0.00112	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CA2—osteoporosis	3.04e-05	0.00112	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TPI1—osteoporosis	2.97e-05	0.00109	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MGLL—osteoporosis	2.97e-05	0.00109	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—IL6—osteoporosis	2.95e-05	0.00108	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PKM—osteoporosis	2.93e-05	0.00108	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—FDPS—osteoporosis	2.93e-05	0.00108	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP19A1—osteoporosis	2.81e-05	0.00103	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TGFB1—osteoporosis	2.79e-05	0.00102	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—P4HB—osteoporosis	2.79e-05	0.00102	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PGLS—osteoporosis	2.78e-05	0.00102	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GPD2—osteoporosis	2.78e-05	0.00102	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GAPDH—osteoporosis	2.74e-05	0.001	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—RAP1A—osteoporosis	2.67e-05	0.000978	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ADCY5—osteoporosis	2.62e-05	0.000959	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GPX1—osteoporosis	2.61e-05	0.000956	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TNF—osteoporosis	2.6e-05	0.000955	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—IL6—osteoporosis	2.59e-05	0.000949	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PNP—osteoporosis	2.54e-05	0.000933	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ATIC—osteoporosis	2.54e-05	0.000933	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—IDH2—osteoporosis	2.52e-05	0.000925	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TGFB1—osteoporosis	2.45e-05	0.000899	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—MTHFR—osteoporosis	2.41e-05	0.000882	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.37e-05	0.000869	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ACP5—osteoporosis	2.31e-05	0.000846	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ADCY5—osteoporosis	2.3e-05	0.000843	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GPX1—osteoporosis	2.29e-05	0.00084	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TNF—osteoporosis	2.29e-05	0.000839	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CA2—osteoporosis	2.16e-05	0.000793	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—OXCT1—osteoporosis	2.16e-05	0.000793	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ENO1—osteoporosis	2.15e-05	0.00079	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TPI1—osteoporosis	2.14e-05	0.000786	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PSMA5—osteoporosis	2.12e-05	0.000779	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PSMA2—osteoporosis	2.12e-05	0.000779	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—MTHFR—osteoporosis	2.11e-05	0.000775	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MGLL—osteoporosis	2.11e-05	0.000773	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—IL6—osteoporosis	2.1e-05	0.000771	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.03e-05	0.000746	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—P4HB—osteoporosis	2.02e-05	0.000739	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GAPDH—osteoporosis	1.98e-05	0.000726	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—RAP1A—osteoporosis	1.93e-05	0.000707	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—POMC—osteoporosis	1.92e-05	0.000706	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PKM—osteoporosis	1.92e-05	0.000704	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—FDPS—osteoporosis	1.92e-05	0.000704	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—IL6—osteoporosis	1.85e-05	0.000677	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PGLS—osteoporosis	1.82e-05	0.000667	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GPD2—osteoporosis	1.82e-05	0.000667	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—IDH2—osteoporosis	1.79e-05	0.000657	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.72e-05	0.000632	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—POMC—osteoporosis	1.69e-05	0.00062	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.69e-05	0.000618	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ATIC—osteoporosis	1.66e-05	0.00061	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PNP—osteoporosis	1.66e-05	0.00061	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ACP5—osteoporosis	1.64e-05	0.000601	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ENO1—osteoporosis	1.56e-05	0.000571	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PSMA2—osteoporosis	1.53e-05	0.000563	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PSMA5—osteoporosis	1.53e-05	0.000563	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TPI1—osteoporosis	1.52e-05	0.000559	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—P4HB—osteoporosis	1.43e-05	0.000526	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CA2—osteoporosis	1.41e-05	0.000519	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.41e-05	0.000519	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADCY5—osteoporosis	1.41e-05	0.000516	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.41e-05	0.000516	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GPX1—osteoporosis	1.4e-05	0.000514	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MGLL—osteoporosis	1.38e-05	0.000506	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.37e-05	0.000502	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MTHFR—osteoporosis	1.29e-05	0.000475	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.25e-05	0.000457	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—IDH2—osteoporosis	1.17e-05	0.00043	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ENO1—osteoporosis	1.11e-05	0.000406	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.1e-05	0.000404	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.09e-05	0.0004	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.09e-05	0.0004	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ACP5—osteoporosis	1.07e-05	0.000393	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—POMC—osteoporosis	1.04e-05	0.00038	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADCY5—osteoporosis	1.02e-05	0.000373	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GPX1—osteoporosis	1.01e-05	0.000372	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TPI1—osteoporosis	9.97e-06	0.000365	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—P4HB—osteoporosis	9.37e-06	0.000344	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MTHFR—osteoporosis	9.36e-06	0.000343	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GAPDH—osteoporosis	9.2e-06	0.000337	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—RAP1A—osteoporosis	8.96e-06	0.000329	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.85e-06	0.000325	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—POMC—osteoporosis	7.48e-06	0.000274	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ENO1—osteoporosis	7.24e-06	0.000266	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADCY5—osteoporosis	7.23e-06	0.000265	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GPX1—osteoporosis	7.21e-06	0.000264	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PSMA5—osteoporosis	7.14e-06	0.000262	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PSMA2—osteoporosis	7.14e-06	0.000262	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MTHFR—osteoporosis	6.65e-06	0.000244	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.79e-06	0.000212	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—POMC—osteoporosis	5.32e-06	0.000195	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADCY5—osteoporosis	4.73e-06	0.000173	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GPX1—osteoporosis	4.71e-06	0.000173	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MTHFR—osteoporosis	4.35e-06	0.00016	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—POMC—osteoporosis	3.48e-06	0.000128	CbGpPWpGaD
